ACEL
Accel Entertainment, Inc.
ACEL has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
ACEL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
ACEL's revenue, profitability, cash flow and balance sheet are all currently healthy.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ACEL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $12.09 | -13% |
| Forward | 16x | $13.83 | — |
| Current | 18x | $13.83 | — |
| Fair | 21x | $15.87 | +15% |
| Expensive | 28x | $20.96 | +52% |
Historical ranges are pointers, not guarantees.
ACEL's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ACEL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ACEL, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ACEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | +16% |
| Q3 2026 | $0.76 | +52% |
| Q2 2026 | $0.67 | +68% |
| Q1 2026 | $0.60 | +22% |
| Q4 2025 | $0.60 | +46% |
| Q3 2025 | $0.50 | -2% |
| Q2 2025 | $0.40 | -30% |
| Q1 2025 | $0.49 | -3.9% |
| Q4 2024 | $0.41 | -23% |
ACEL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ACEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $363.6M | +10% |
| Q2 2026 | $368.1M | +9.6% |
| Q1 2026 | $351.6M | +8.5% |
| Q4 2025 | $341.4M | +7.5% |
| Q3 2025 | $329.7M | +9.1% |
| Q2 2025 | $335.9M | +8.6% |
| Q1 2025 | $323.9M | +7.3% |
| Q4 2024 | $317.5M | +6.9% |
ACEL's revenue has grown year over year for 23 quarters in a row: $364M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | +0.2 points |
| Q2 2026 | 8.7% | +0.7 points |
| Q1 2026 | 7.7% | -0.3 points |
| Q4 2025 | 8.7% | +2.1 points |
| Q3 2025 | 7.7% | +0.5 points |
| Q2 2025 | 8% | +0.7 points |
| Q1 2025 | 8% | -0.5 points |
| Q4 2024 | 6.5% | -2 points |
ACEL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ACEL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ACEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | +77% |
| Q2 2026 | $8.9M | +$15.1M |
| Q1 2026 | $19.9M | +10% |
| Q4 2025 | $16M | +670% |
| Q3 2025 | $34.2M | +3.4% |
| Q2 2025 | -$6.2M | -155% |
| Q1 2025 | $18M | +122% |
| Q4 2024 | $2.1M | -89% |
ACEL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ACEL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -15K shares |
| 1 year | -3.1% | -2.7M shares |
| 3 years | -4.3% | -3.7M shares |
| 5 years | -12% | -11.3M shares |
| Available history | +6.9% | +5.4M shares |
ACEL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $7.2M |
| Q2 2026 | $5.6M |
| Q1 2026 | $12.1M |
| Q4 2025 | $16.2M |
| Q3 2025 | $6.8M |
| Q2 2025 | $6.7M |
| Q1 2025 | $10.2M |
| Q4 2024 | $4M |
ACEL spent $41M buying back its own shares over the past year, up 48% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ACEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 2.0x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.3x | Moderate |
ACEL's net debt is about 1.6 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ACEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.7 | Neutral |
| Stochastic | 74.0 | Neutral |
ACEL's weekly RSI is 70 (neutral) and its Stochastic is 74 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ACEL PE vs Consumer Cyclical Sector
| Metric | ACEL | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 1% above |
| PE % | 27 | 47 | 20 pts below |
ACEL is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ACEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.7 | 18% above |
| 20 week MA | $11.9 | 16% above |
| 50 week MA | $11.8 | 18% above |
| 100 week MA | $11.4 | 21% above |
| 200 week MA | $10.9 | 26% above |
ACEL has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ACEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.3 | $10.9 | -12% |
| 2021 | $10.9 | $13.2 | +21% |
| 2022 | $13.2 | $7.57 | -43% |
| 2023 | $7.57 | $10.3 | +36% |
| 2024 | $10.3 | $10.6 | +3.6% |
| 2025 | $10.6 | $11.7 | +10% |
| 2026 YTD | $11.7 | $13.8 | +18% |
ACEL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.